95 related articles for article (PubMed ID: 9711228)
1. The first total synthesis of natural (+)-terpestacin, syncytium formation inhibitor.
Tatsuta K; Masuda N
J Antibiot (Tokyo); 1998 Jun; 51(6):602-6. PubMed ID: 9711228
[No Abstract] [Full Text] [Related]
2. Terpestacin, a new syncytium formation inhibitor from Arthrinium sp.
Oka M; Iimura S; Tenmyo O; Sawada Y; Sugawara M; Ohkusa N; Yamamoto H; Kawano K; Hu SL; Fukagawa Y
J Antibiot (Tokyo); 1993 Mar; 46(3):367-73. PubMed ID: 8478254
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective synthesis of (-)-terpestacin and (-)-fusaproliferin: clarification of optical rotational measurements and absolute configurational assignments establishes a homochiral structural series.
Myers AG; Siu M; Ren F
J Am Chem Soc; 2002 Apr; 124(16):4230-2. PubMed ID: 11960450
[TBL] [Abstract][Full Text] [Related]
4. Total synthesis of (+/-)-terpestacin and (+/-)-11-epi-terpestacin.
Berger GO; Tius MA
J Org Chem; 2007 Aug; 72(17):6473-80. PubMed ID: 17630803
[TBL] [Abstract][Full Text] [Related]
5. The structure of cyclooctatin, a new inhibitor of lysophospholipase.
Aoyama T; Naganawa H; Muraoka Y; Aoyagi T; Takeuchi T
J Antibiot (Tokyo); 1992 Oct; 45(10):1703-4. PubMed ID: 1474002
[No Abstract] [Full Text] [Related]
6. Alteration of membrane polarization by (-)-terpestacin, a biologically active fungal metabolite.
Grigoriev PA; Schlegel B; Schmidtke M; Gräfe U
Pharmazie; 2002 Sep; 57(9):653-4. PubMed ID: 12369460
[No Abstract] [Full Text] [Related]
7. Synthesis of (-)-terpestacin via catalytic, stereoselective fragment coupling: siccanol is terpestacin, not 11-epi-terpestacin.
Chan J; Jamison TF
J Am Chem Soc; 2003 Sep; 125(38):11514-5. PubMed ID: 13129351
[TBL] [Abstract][Full Text] [Related]
8. Nosporins A and B, new metabolites from a filamentous fungus, VKM-3750.
Kozlovsky AG; Zhelifonova VP; Adanin VM; Ozerskaya SM; Gräfe U
Pharmazie; 2003 Jan; 58(1):76-7. PubMed ID: 12622263
[No Abstract] [Full Text] [Related]
9. Asymmetric total synthesis of (+)- and (-)-clusianone and (+)- and (-)-clusianone methyl enol ether via ACC alkylation and evaluation of their anti-HIV activity.
Garnsey MR; Matous JA; Kwiek JJ; Coltart DM
Bioorg Med Chem Lett; 2011 Apr; 21(8):2406-9. PubMed ID: 21414776
[TBL] [Abstract][Full Text] [Related]
10. Enantioselective synthesis of (-)-terpestacin and structural revision of siccanol using catalytic stereoselective fragment couplings and macrocyclizations.
Chan J; Jamison TF
J Am Chem Soc; 2004 Sep; 126(34):10682-91. PubMed ID: 15327327
[TBL] [Abstract][Full Text] [Related]
11. A diosphenol-based strategy for the total synthesis of (-)-terpestacin.
Trost BM; Dong G; Vance JA
J Am Chem Soc; 2007 Apr; 129(15):4540-1. PubMed ID: 17343388
[No Abstract] [Full Text] [Related]
12. Asymmetric synthesis and biological activity of L-bicyclocarba-d4T.
Moon HR; Park AY; Kim KR; Chun MW; Jeong LS
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1653-7. PubMed ID: 18066846
[TBL] [Abstract][Full Text] [Related]
13. Short route to platencin.
Yadav JS; Goreti R; Pabbaraja S; Sridhar B
Org Lett; 2013 Jul; 15(14):3782-5. PubMed ID: 23834636
[TBL] [Abstract][Full Text] [Related]
14. A convergent stereocontrolled total synthesis of (-)-terpestacin.
Jin Y; Qiu FG
Org Biomol Chem; 2012 Jul; 10(28):5452-5. PubMed ID: 22710980
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of some N,N'-disubstituted derivatives of bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide with an expected activity on central nervous system.
Turło J; Zawadowski T
Acta Pol Pharm; 1994; 51(4-5):347-9. PubMed ID: 7701948
[No Abstract] [Full Text] [Related]
16. Terpestacin core structure. control of stereochemistry.
Berger GO; Tius MA
Org Lett; 2005 Oct; 7(22):5011-3. PubMed ID: 16235945
[TBL] [Abstract][Full Text] [Related]
17. A facile Diels-Alder reaction with benzene: synthesis of the bicyclo[2.2.2]octene skeleton promoted by rhenium.
Chordia MD; Smith PL; Meiere SH; Sabat M; Harman WD
J Am Chem Soc; 2001 Oct; 123(43):10756-7. PubMed ID: 11674016
[No Abstract] [Full Text] [Related]
18. The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors.
Yuan D; He M; Pang R; Lin SS; Li Z; Yang M
Bioorg Med Chem; 2007 Jan; 15(1):265-72. PubMed ID: 17055732
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Novel Nucleoside Analogues Built on a Bicyclo[4.1.0]heptane Scaffold.
Domínguez-Pérez B; Ferrer É; Figueredo M; Maréchal JD; Balzarini J; Alibés R; Busqué F
J Org Chem; 2015 Oct; 80(19):9495-505. PubMed ID: 26376319
[TBL] [Abstract][Full Text] [Related]
20. Hyperforin.
Beerhues L
Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
